232 related articles for article (PubMed ID: 26870991)
21. NOTCH1 Signaling Regulates Self-Renewal and Platinum Chemoresistance of Cancer Stem-like Cells in Human Non-Small Cell Lung Cancer.
Zhang Y; Xu W; Guo H; Zhang Y; He Y; Lee SH; Song X; Li X; Guo Y; Zhao Y; Ding C; Ning F; Ma Y; Lei QY; Hu X; Li S; Guo W
Cancer Res; 2017 Jun; 77(11):3082-3091. PubMed ID: 28416482
[TBL] [Abstract][Full Text] [Related]
22. Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non-Small Cell Lung Cancer.
Song M; Ping Y; Zhang K; Yang L; Li F; Zhang C; Cheng S; Yue D; Maimela NR; Qu J; Liu S; Sun T; Li Z; Xia J; Zhang B; Wang L; Zhang Y
Cancer Res; 2019 Jul; 79(14):3737-3748. PubMed ID: 31085700
[TBL] [Abstract][Full Text] [Related]
23. Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid.
Yoshiyama A; Morii T; Ohtsuka K; Ohnishi H; Tajima T; Aoyagi T; Mochizuki K; Satomi K; Ichimura S
Anticancer Res; 2016 Feb; 36(2):625-31. PubMed ID: 26851017
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
[TBL] [Abstract][Full Text] [Related]
25. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition.
Thomson S; Buck E; Petti F; Griffin G; Brown E; Ramnarine N; Iwata KK; Gibson N; Haley JD
Cancer Res; 2005 Oct; 65(20):9455-62. PubMed ID: 16230409
[TBL] [Abstract][Full Text] [Related]
26. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.
Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY
Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022
[TBL] [Abstract][Full Text] [Related]
27. Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer.
Ma Y; Yang X; Zhao W; Yang Y; Zhang Z
Cell Death Dis; 2021 Mar; 12(3):257. PubMed ID: 33707423
[TBL] [Abstract][Full Text] [Related]
28. A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
Li J; Viallet J; Haura EB
Cancer Chemother Pharmacol; 2008 Mar; 61(3):525-34. PubMed ID: 17505826
[TBL] [Abstract][Full Text] [Related]
29. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer.
Airoldi I; Tupone MG; Esposito S; Russo MV; Barbarito G; Cipollone G; Di Carlo E
Oncotarget; 2015 Feb; 6(6):3694-708. PubMed ID: 25638163
[TBL] [Abstract][Full Text] [Related]
31. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
32. Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
Howe GA; Xiao B; Zhao H; Al-Zahrani KN; Hasim MS; Villeneuve J; Sekhon HS; Goss GD; Sabourin LA; Dimitroulakos J; Addison CL
PLoS One; 2016; 11(3):e0150567. PubMed ID: 26962872
[TBL] [Abstract][Full Text] [Related]
33. Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts.
Lev-Ari S; Starr A; Katzburg S; Berkovich L; Rimmon A; Ben-Yosef R; Vexler A; Ron I; Earon G
J Nutr Biochem; 2014 Aug; 25(8):843-50. PubMed ID: 24835302
[TBL] [Abstract][Full Text] [Related]
34. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
35. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
[TBL] [Abstract][Full Text] [Related]
36. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of β-Catenin enhances the anticancer effect of irreversible EGFR-TKI in EGFR-mutated non-small-cell lung cancer with a T790M mutation.
Togashi Y; Hayashi H; Terashima M; de Velasco MA; Sakai K; Fujita Y; Tomida S; Nakagawa K; Nishio K
J Thorac Oncol; 2015 Jan; 10(1):93-101. PubMed ID: 25384171
[TBL] [Abstract][Full Text] [Related]
38. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
39. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
[TBL] [Abstract][Full Text] [Related]
40. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.
Xie M; He CS; Wei SH; Zhang L
Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]